Katherine E. Agre

Katherine E. Agre

Auto-generated profile, based on publicly available information

Katherine E. Agre

Mayo Clinic, Rochester MN, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2019 in Nature Reviews Cardiology
Verified
Journal Article
Closed access
PDF file
ARAndrew N. Rosenbaum
Andrew N. Rosenbaum
KAKatherine E. Agre
Katherine E. Agre
NPNaveen L. Pereira
Naveen L. Pereira

11 October 2019 in Journal of Genetic Counseling
Verified
Journal Article
Closed access
PDF file
KAKatherine Agre
Katherine Agre
PVPatricia McCarthy Veach
Patricia McCarthy Veach
HBHeather Bemmels
Heather Bemmels
KWKatie Wiens
Katie Wiens
BLBonnie S. LeRoy
Bonnie S. LeRoy
MHMaria Hordinsky
Maria Hordinsky

31 March 2021 in Journal of Genetic Counseling
Verified
Journal Article
Closed access
PDF file
KAKatherine Agre
Katherine Agre
AEAnna Essendrup
Anna Essendrup
CKChristine Koellner
Christine Koellner
LRLaura Rust
Laura Rust
DDDavid Deyle
David Deyle

9 August 2021 in medRxiv
Verified
Preprint
Open access
PDF file
JSJanina Sörmann
Janina Sörmann
MSMarcus Schewe
Marcus Schewe
PPPeter Proks
Peter Proks
TJThibault Jouen-Tachoire
Thibault Jouen-Tachoire
SRShanlin Rao
Shanlin Rao
STStephen Tucker
Stephen Tucker
Sleep apnea is a common disorder that represents a global public health burden. KCNK3 encodes TASK-1, a K + channel implicated in the control of breathing, but its link with sleep apnea remains poorly understood. Here we describe a novel developmental disorder with sleep apnea caused by rare de novo gain-of-function mutations in KCNK3 . The mutations cluster around the ‘X-gate’, a gating motif which controls channel opening, and produce overactive channels that no longer respond to inhibition by G-protein coupled receptor pathways, but which can be inhibited by several clinically relevant drugs. These findings demonstrate a clear role for TASK-1 in sleep apnea and identify possible therapeutic strategies.